# Dyne Therapeutics, Inc.: Form 8-K, filed Sep 12, 2022

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: 8-K
- Filed: 2022-09-12
- Accepted by EDGAR: Sep 12, 2022, 07:07 ET
- Period: 2022-09-06
- Accession: 0000950170-22-018315
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000095017022018315/dyn-20220906.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000095017022018315/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000095017022018315/dyn-20220906.htm

Filed Sep 12, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-018315. Last ingested by Listed: Nov 5, 2026, 12:06 ET. No prices; not investment advice.